| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/04/2007 | EP1472246B1 Oxadiazoles having antiproliferative activity |
| 04/04/2007 | CN1942551A New organic luminescent element |
| 04/04/2007 | CN1942466A Caspase inhibitors and uses thereof |
| 04/04/2007 | CN1942449A Process for preparing pyridazinone compounds |
| 04/04/2007 | CN1942440A Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives |
| 04/04/2007 | CN1942428A CETP inhibitors |
| 04/04/2007 | CN1942419A Method for establishing CC bonds between electrophilic substrates and pi - nucleophiles in neutral to alkaline aqueous or alcoholic solvents without using a lewis or bronsted acid |
| 04/04/2007 | CN1939906A Synthesis of DL-tryptophane-alpha-N |
| 04/04/2007 | CN1939905A Indole acrylic acid derivative and its use for preparing immune inhibitor |
| 04/04/2007 | CN1939884A Novel aromatic compound and organic electroluminescnet element containing the same |
| 04/04/2007 | CN1308307C Pseudopolymorphic forms of carvedilol |
| 04/04/2007 | CN1308306C 2-aryl-trisubstituted indole acetamide derivative and medicinal use thereof |
| 04/04/2007 | CN1308305C Method for synthesizing imide base substituted endo compound |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1308288C New amide ramification of sweetsop as well as its preparing method, its medication composition and usage |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199264 Separating alanine isomers from a racemic mixture, by amidation converting a nitrogen atom of an amino group into carbamate group, complexing with hydrophilic compound, isolate by the difference in the hydrophobicity; purification |
| 04/03/2007 | US7199148 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 04/03/2007 | US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example |
| 04/03/2007 | CA2397545C Method of detecting dna by dna hybridization method with the use of fluorescent resonance energy transfer |
| 04/03/2007 | CA2281918C Oxazolidines as 5-ht2a-antagonists |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 04/03/2007 | CA2181006C N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 03/29/2007 | WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 03/29/2007 | WO2007015809A3 Hiv reverse transcriptase inhibitors |
| 03/29/2007 | WO2007008985A3 Kinase inhibitors |
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/29/2007 | WO2007000340A3 Bicyclic derivatives as p38 kinase inhibitors |
| 03/29/2007 | WO2006128142A3 Inhibitors of cytosolic phospholipase a2 |
| 03/29/2007 | WO2006108864A3 New nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof |
| 03/29/2007 | WO2006029697A8 Perfected process for the preparation of stable nitroxide radicals |
| 03/29/2007 | WO2005112640A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 03/29/2007 | WO2005109987A9 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 03/29/2007 | US20070073093 Light emitting device and compounds for use therein |
| 03/29/2007 | US20070072942 Statin derivatives |
| 03/29/2007 | US20070072935 Catalytic antioxidants and methods of use |
| 03/29/2007 | US20070072919 Preparing perindopril by reacting 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanine and octahydro 1H-indole-2-carboxylic acid or its ester with a uronium salt (O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) in the presence of a tertiary amine in an aprotic solvent |
| 03/29/2007 | US20070072911 Indoles and azaindoles as antiviral agents |
| 03/29/2007 | US20070072902 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 03/29/2007 | US20070072854 such as 6-(nitrooxy)hexanoic acid 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol hydrochloride; adrenergic blocking agents; for treatment of hypertension, cardiovascular diseases, glaucoma, migraine headache and vascular diseases |
| 03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 03/29/2007 | US20070069197 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles |
| 03/29/2007 | CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 03/29/2007 | CA2621720A1 Carbazole derivatives |
| 03/28/2007 | EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage |
| 03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| 03/28/2007 | EP1765819A1 Azaindoles useful as inhibitors of protein kinases |
| 03/28/2007 | EP1765776A1 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs) |
| 03/28/2007 | EP1765775A1 Indoles useful in the treatment of inflammation |
| 03/28/2007 | EP1765329A2 Indoles having anti-diabetic activity |
| 03/28/2007 | EP1353890B1 Obtaining anthracene and carbazole by melt-crystallization |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 03/28/2007 | CN1938311A Macrocyclic compounds as inhibitors of viral replication |
| 03/28/2007 | CN1938304A Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 03/28/2007 | CN1938273A Tetrahydrocarbazoles and derivatives |
| 03/28/2007 | CN1938272A Crystalline polymorph of bazedoxifene acetate |
| 03/28/2007 | CN1938271A Crystalline polymorph of bazedoxifene acetate |
| 03/28/2007 | CN1938244A Fluoridation method |
| 03/28/2007 | CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/27/2007 | US7196204 Method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril |
| 03/27/2007 | US7196203 Phenol derivatives and method of use thereof |
| 03/27/2007 | US7196199 Phenoxypropylamine compounds |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
| 03/22/2007 | WO2007032551A1 Hemodynamics improving agent |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007031429A1 Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 03/22/2007 | WO2007030939A2 Methods of modulating neurotrophin-mediated activity |
| 03/22/2007 | WO2007004165A3 Process for the preparation of perindopril |
| 03/22/2007 | US20070066833 Methods to synthesize indoles as precursors for pharmaceuticals |
| 03/22/2007 | US20070066832 Method for producing monatin |
| 03/22/2007 | US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates |
| 03/22/2007 | US20070066637 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | CA2622571A1 Methods of modulating neurotrophin-mediated activity |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764357A1 Selective androgen receptor modulators and methods of use thereof |
| 03/21/2007 | EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 03/21/2007 | EP1763513A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 03/21/2007 | EP1763512A2 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | CN1934911A 芳基胺化合物和有机电致发光器件 Aryl amine compounds and organic electroluminescent devices |
| 03/21/2007 | CN1934237A Granular compositions |
| 03/21/2007 | CN1934117A Macrolides and methods for producing same |
| 03/21/2007 | CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
| 03/21/2007 | CN1934082A Organic compounds |
| 03/21/2007 | CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors |
| 03/21/2007 | CN1931840A DNA target molecules and their application in inducing apoptosis and antagonizing tumor |
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/21/2007 | CN1305873C [18F] Fluorin marked pyridine compound and method for preparing the same and uses as dopamine D4 receptor developer |
| 03/21/2007 | CN1305853C Process for the manufacture of HMG-coa reductase inhibitors |
| 03/21/2007 | CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity |
| 03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192977 Duocamycin prodrugs; binding to Dna |
| 03/20/2007 | US7192969 Ester derivatives |